Back to Search
JOSEPH ROSENBLUM, DO
DO
Internal Medicine Physician
NPI: 1609861509IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
02001043A(IN)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
02001043A(IN)
Interventional Cardiology Physician
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
02001043A(IN)
Vascular & Interventional Radiology Physician
Radiology — Vascular & Interventional Radiology
Code: 2085R0204X
02001043A(IN)
Diagnostic Ultrasound Physician
Radiology — Diagnostic Ultrasound
Code: 2085U0001X
02001043A(IN)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 1983
Research & Publications (20)
Management of anorexia nervosa with exercise and selective serotonergic reuptake inhibitors.
PMID 12806270·Curr Opin Pediatr·2003
6-review
Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.
PMID 12941425·Curr Opin Chem Biol·2003
6-review
CCR5 is required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts.
PMID 19656127·Am J Transplant·2009
7-preclinical
Best practice updates for pediatric/adolescent weight loss surgery.
PMID 19396070·Obesity (Silver Spring)·2009
6-review
Invasive treatment of claudication is indicated for patients unable to adequately ambulate during cardiac rehabilitation.
PMID 19394551·J Vasc Surg·2009
8-other
Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.
PMID 19389928·Am J Pathol·2009
7-preclinical
CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival.
PMID 19202440·Transplantation·2009
7-preclinical
Cost-effectiveness of new cardiac and vascular rehabilitation strategies for patients with coronary artery disease.
PMID 19065259·PLoS One·2008
8-other
Chemokine-directed strategies to attenuate allograft rejection.
PMID 19028262·Clin Lab Med·2008
6-review
CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice.
PMID 18832680·J Immunol·2008
7-preclinical
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
PMID 18338812·Cancer·2008
8-other
Polo-like kinases inhibited by wortmannin. Labeling site and downstream effects.
PMID 17135248·J Biol Chem·2007
8-other
Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor.
PMID 17055271·Bioorg Med Chem Lett·2007
8-other
Percutaneous treatment of venous outflow obstruction in pediatric liver transplants.
PMID 17142705·J Vasc Interv Radiol·2006
8-other
Boro-norleucine as a P1 residue for the design of selective and potent DPP7 inhibitors.
PMID 16084722·Bioorg Med Chem Lett·2005
8-other
Synthesis and structure-activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7.
PMID 16085416·Bioorg Med Chem Lett·2005
8-other
Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase.
PMID 15664519·Chem Biol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 824 LINCOLNWAY, LOFT #2
LA PORTE, IN 46350 - Phone
- (219) 380-5724
Quick Facts
- NPI
- 1609861509
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 5
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile